CLINICAL DETECTION OF BCR-ABL FUSION BY INSITU HYBRIDIZATION IN CHRONIC MYELOGENOUS LEUKEMIA

被引：30
|
作者：
AMIEL, A
YARKONI, S
FEJGIN, M
GABER, E
NAGLER, A
MANOR, Y
LISHNER, M
机构：
[1] HADASSAH UNIV HOSP,DEPT BONE MARROW TRANSPLANTAT,JERUSALEM,ISRAEL
[2] MEIR HOSP,HEMATOL UNIT,IL-44281 KEFAR SAVA,ISRAEL
来源：
CANCER GENETICS AND CYTOGENETICS | 1993年 / 65卷 / 01期
关键词：
D O I：
10.1016/0165-4608(93)90055-Q
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We describe the use of the fluorescence in situ hybridization (FISH) technique to detect residual Philadelphia chromosome-positive (Ph+) cells in a patient with blastic phase chronic myelogenous leukemia (CML) after aggressive cytoreductive treatment. The analysis was made in interphase nuclei because of the very small number of recognizable metaphases in leukemic patients. FISH was a reliable tool for the detection of chromosome translocations in interphase nuclei as compared with conventional cytogenetic and polymerase chain reaction (PCR) techniques.
引用
收藏
页码：32 / 34
页数：3
相关论文
共 50 条
  • [1] DETECTION OF BCR-ABL FUSION IN CHRONIC MYELOGENEOUS LEUKEMIA BY INSITU HYBRIDIZATION
    TKACHUK, DC
    WESTBROOK, CA
    ANDREEFF, M
    DONLON, TA
    CLEARY, ML
    SURYANARAYAN, K
    HOMGE, M
    REDNER, A
    GRAY, J
    PINKEL, D
    LABORATORY INVESTIGATION, 1991, 64 (01) : A85 - A85
  • [2] DETECTION OF BCR-ABL FUSION IN CHRONIC MYELOGENEOUS LEUKEMIA BY INSITU HYBRIDIZATION
    TKACHUK, DC
    WESTBROOK, CA
    ANDREEFF, M
    DONLON, TA
    CLEARY, ML
    SURYANARAYAN, K
    HOMGE, M
    REDNER, A
    GRAY, J
    PINKEL, D
    SCIENCE, 1990, 250 (4980) : 559 - 562
  • [3] THE BCR-ABL GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    SAWYERS, CL
    CANCER SURVEYS, 1992, 15 : 37 - 51
  • [4] Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia
    Min, CK
    Yang, IH
    Kim, DW
    Lee, JW
    Han, CW
    Min, WS
    Kim, CC
    ACTA HAEMATOLOGICA, 2000, 104 (2-3) : 135 - 138
  • [5] Frequency of BCR-ABL Fusion Transcripts in Saudi Patients with Chronic Myelogenous Leukemia
    Elbjeirami, W. M.
    Abdulwahab, A.
    Elsayed, H.
    Elnagdi, N.
    Abd Allatif, N.
    Al-Jedani, H.
    Al Shaikh, A.
    Al-Allaf, F. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 766 - 766
  • [6] ACTIVATION OF BCR-ABL FUSION GENE AND RAS ONCOGENES IN CHRONIC MYELOGENOUS LEUKEMIA
    FUTAKI, M
    INOKUCHI, K
    DAN, K
    NOMURA, T
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 163 - 169
  • [7] BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia
    Gruenebach, Frank
    Mirakaj, Valbona
    Mirakaj, Valdete
    Mueller, Martin R.
    Bruemmendorf, Tim
    Brossart, Peter
    CANCER RESEARCH, 2006, 66 (11) : 5892 - 5900
  • [8] BCR-ABL RNA IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    SHTIVELMAN, E
    GALE, RP
    DREAZEN, O
    BERREBI, A
    ZAIZOV, R
    KUBONISHI, I
    MIYOSHI, I
    CANAANI, E
    BLOOD, 1987, 69 (03) : 971 - 973
  • [9] Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia.
    Min, CK
    Yang, LH
    Kim, DW
    Lee, JW
    Min, WS
    Kim, CC
    BLOOD, 1999, 94 (10) : 277B - 277B
  • [10] Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells
    J. L. Fernandez-Luna
    Apoptosis, 2000, 5 : 315 - 318
12345